-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Immuneering Corp quarterly/annual Depreciation history and growth rate from Q2 2020 to Q1 2024.
- Immuneering Corp Depreciation for the quarter ending March 31, 2024 was $90.2K, a 17.9% increase year-over-year.
- Immuneering Corp annual Depreciation for 2023 was $323K, a 30.6% increase from 2022.
- Immuneering Corp annual Depreciation for 2022 was $247K, a 444% increase from 2021.
- Immuneering Corp annual Depreciation for 2021 was $45.5K, a 86.9% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)